Overview
KVP Team
Caley Castelein
Anupam Dalal
Andrew Jensen
Jim Shapiro
Dick Spalding
Venture Partners
David Bradford
Mike Chobotov
Richard Glickman
Senior Advisors
Victor Dzau
Don Ganem
Peter Hutt
Fred Moll
Thomas Weisel
|
Richard Glickman was the co-founder, Chairman and Chief Executive Officer of Aspreva Pharmaceuticals Corporation, a 2003 fund portfolio company. In 2007, Galencia purchased Aspreva for $915mn. Prior to establishing Aspreva, Mr. Glickman was the co-founder and Chief Executive Officer of Stressgen Biotechnologies Corporation.
Mr. Glickman has served on numerous biotechnology boards including roles as Chairman of Life Sciences British Columbia (formerly the British Columbia Biotechnology Alliance), Director of the Canadian Genetic Disease Network and as a member of the federal government's National Biotechnology Advisory Committee.
|
|
